Fulvia Troise

861 total citations
25 papers, 491 citations indexed

About

Fulvia Troise is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Fulvia Troise has authored 25 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Oncology. Recurrent topics in Fulvia Troise's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (9 papers) and Virus-based gene therapy research (6 papers). Fulvia Troise is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (9 papers) and Virus-based gene therapy research (6 papers). Fulvia Troise collaborates with scholars based in Italy, United States and United Kingdom. Fulvia Troise's co-authors include Graciana Diez‐Roux, Mario Buono, Claudia De Lorenzo, Valeria Cafaro, Alfredo Nicosia, Elisa Scarselli, Giuseppe D’Alessio, Guido Leoni, Anna Morena D’Alise and Concetta Giancola and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Fulvia Troise

24 papers receiving 481 citations

Peers

Countries citing papers authored by Fulvia Troise

Since Specialization

Citations

This map shows the geographic impact of Fulvia Troise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulvia Troise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulvia Troise more than expected).

Fields of papers citing papers by Fulvia Troise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fulvia Troise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulvia Troise. The network helps show where Fulvia Troise may publish in the future.

Co-authorship network of co-authors of Fulvia Troise

This figure shows the co-authorship network connecting the top 25 collaborators of Fulvia Troise. A scholar is included among the top collaborators of Fulvia Troise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fulvia Troise. Fulvia Troise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine 2024 ·Cancer Immunology Research ·(unknown), Linda Nocchi, Lidia Avalle, Fulvia Troise, Guido Leoni, Laura Seclì, Laura Antonucci, Gabriella Cotugno, (unknown), Giuseppina Colonna Romano, Laura Conti, (unknown), (unknown), Valeria Poli, Elisa Scarselli, Anna Morena D’Alise	4
2	Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors 2024 ·SHILAP Revista de lepidopterología ·Fulvia Troise, Guido Leoni, Emanuele Sasso, Mariarosaria Del Sorbo, (unknown), Giuseppina Colonna Romano, (unknown), (unknown), Gabriella Cotugno, Stefania Capone, Antonella Folgori, Elisa Scarselli, Anna Morena D’Alise, Alfredo Nicosia	1
3	Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine 2024 ·Vaccines ·Rosa Bartolomeo, Fulvia Troise, (unknown), Giulia Sdruscia, Rosa Vitale, (unknown), Anna Maria Petrone, Giuseppina Colonna Romano, Anna Morena D’Alise, Valentino Ruzza, (unknown), Guido Leoni, (unknown), (unknown), Stefano Colloca, (unknown), Elisa Scarselli, Gabriella Cotugno	0
4	Abstract B053: Neoadjuvant Personalized Viral Vectored vaccines are highly effective against tumor relapse in checkpoint inhibitor resistant murine models 2024 ·Cancer Immunology Research ·Anna Morena D’Alise, Laura Seclì, Linda Nocchi, Guido Leoni, Gabriella Cotugno, Fulvia Troise, Elisa Micarelli, (unknown), Laura Antonucci, Elisa Scarselli	1
5	Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity 2023 ·Journal for ImmunoTherapy of Cancer ·Laura Seclì, (unknown), Linda Nocchi, (unknown), Gabriella Cotugno, Guido Leoni, Elisa Micarelli, (unknown), Lidia Avalle, Giulia Sdruscia, Fulvia Troise, (unknown), Giuseppina Colonna Romano, Elisa Scarselli, Anna Morena D’Alise	5
6	Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer 2023 ·Frontiers in Immunology ·Anna Morena D’Alise, Linda Nocchi, (unknown), Laura Seclì, (unknown), Fulvia Troise, Gabriella Cotugno, (unknown), Giuseppina Colonna Romano, Armin Lahm, Guido Leoni, Emanuele Sasso, Elisa Scarselli, Alfredo Nicosia	7
7	In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus 2021 ·PLoS Pathogens ·(unknown), (unknown), Fulvia Troise, Jens Bukh, Jannick Prentoe	6
8	Adenovirus vectors activate Vδ2 ⁺ γδT cells in a type I interferon‐, TNF‐, and IL‐18‐dependent manner 2021 ·European Journal of Immunology ·Nicholas M. Provine, Ali Amini, Lucy C. Garner, Michael Fitzpatrick, Christina Dold, Laura Silva-Reyes, Senthil Chinnakannan, Blanché Oguti, (unknown), Fulvia Troise, Stefania Capone, Antonella Folgori, Eleanor Barnes, Christine S. Rollier, Andrew J. Pollard, Paul Klenerman	4
9	Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis 2019 ·Cardiovascular Research ·Lauriane Galle-Treger, Martine Moreau, Raphaëlle Ballaire, Lucie Poupel, (unknown), Emanuele Sasso, Fulvia Troise, Francesco Potì, Philippe Lesnik, Wilfried Le Goff, Emmanuel L. Gautier, Thierry Huby	21
10	Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanoma 2019 ·Veterinary and Comparative Oncology ·Diana Giannuzzi, Laura Marconato, Ramy Elgendy, Serena Ferraresso, Elisa Scarselli, Piero Fariselli, Alfredo Nicosia, Sara Pegolo, Guido Leoni, Paola Laganga, (unknown), Mery Giantin, Fulvia Troise, Mauro Dacasto, Luca Aresu	10
11	Multimerization and Retention of the Scavenger Receptor SR-B1 in the Plasma Membrane 2019 ·Developmental Cell ·Pedro Elias Marques, (unknown), Richard F. Collins, Fulvia Troise, Spencer A. Freeman, William S. Trimble, Sergio Grinstein	33
12	Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade 2019 ·Nature Communications ·Anna Morena D’Alise, Guido Leoni, Gabriella Cotugno, Fulvia Troise, Francesca Langone, (unknown), (unknown), Lidia Avalle, Rosa Vitale, (unknown), (unknown), (unknown), (unknown), Valeria Poli, Armin Lahm, Maria Teresa Catanese, Antonella Folgori, Stefano Colloca, Alfredo Nicosia, Elisa Scarselli	76
13	Lipophilicity is a key factor to increase the antiviral activity of HIV neutralizing antibodies 2017 ·Colloids and Surfaces B Biointerfaces ·Marcelo T. Augusto, Axel Hollmann, Fulvia Troise, Ana Salomé Veiga, Antonello Pessi, Nuno C. Santos	7
14	Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice 2015 ·Gut ·Koen Vercauteren, Richard J. P. Brown, Ahmed Atef Mesalam, Juliane Doerrbecker, Sabin Bhuju, Robert Geffers, (unknown), C. Patrick McClure, Fulvia Troise, Lieven Verhoye, Thomas F. Baumert, Ali Farhoudi, Riccardo Cortese, Jonathan K. Ball, Geert Leroux‐Roels, Thomas Pietschmann, Alfredo Nicosia, Philip Meuleman	22
15	Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation 2014 ·Journal of Biological Chemistry ·(unknown), Richard A. Urbanowicz, Fulvia Troise, Claudia De Lorenzo, Valeria Severino, Antimo Di Maro, Alexander W. Tarr, Francesca Ferrara, Alexander Ploß, Nigel Temperton, Jonathan K. Ball, Alfredo Nicosia, Riccardo Cortese, Antonello Pessi	16
16	A novel ErbB2 epitope targeted by human antitumor immunoagents 2011 ·FEBS Journal ·Fulvia Troise, Maria Monti, Antonello Merlino, Flora Cozzolino, Carmine Fedele, Irene Russo Krauss, Filomena Sica, Piero Pucci, Giuseppe D’Alessio, Claudia De Lorenzo	12
17	Differential binding of human immunoagents and Herceptin to the ErbB2 receptor 2008 ·FEBS Journal ·Fulvia Troise, Valeria Cafaro, Concetta Giancola, (unknown), Claudia De Lorenzo	37
18	Intracellular route and mechanism of action of ERB‐hRNase, a human anti‐ErbB2 anticancer immunoagent 2007 ·FEBS Letters ·Claudia De Lorenzo, Chiara Di Malta, Gaetano Calı̀, Fulvia Troise, Lucio Nitsch, Giuseppe D’Alessio	24
19	Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin 2007 ·British Journal of Cancer ·Claudia De Lorenzo, Fulvia Troise, Valeria Cafaro, Giuseppe D’Alessio	13
20	Optineurin Increases Cell Survival and Translocates to the Nucleus in a Rab8-dependent Manner upon an Apoptotic Stimulus 2006 ·Journal of Biological Chemistry ·(unknown), Mario Buono, Fulvia Troise, Graciana Diez‐Roux	103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact